EULAR press releases

EULAR news archive

News of December 2017

7. Dec. 2017

Press release: EULAR Recommendations

Actively optimising patient care in rheumatism: Contribution to and dissemination of key scientific findings in rheumatology are set out in the EULAR Recommendations – and translated into lay versions as well as local languages across Europe

News of October 2017

17. Oct. 2017

Press release: Investment beyond 2020

EULAR has called on the European Commission to maintain the EU’s position as global leader in health research. This includes continuing investment in research and developing a forward-looking agenda beyond the current research framework programme, Horizon 2020.

News of July 2017

6. Jul. 2017

EULAR School of Rheumatology Launch A 'Benefit to Humanity'

New ‘one roof structure’ for EULAR educational offerings, services and products gives international rheumatology community access to cutting-edge continued professional development.

5. Jul. 2017

New Editor for Annals of the Rheumatic Diseases

BMJ, a leading healthcare knowledge provider, is pleased to announce Josef Smolen as the new editor of Annals of the Rheumatic Diseases (ARD).

ARD is the top ranked journal in the field of rheumatology with an impact factor of 12.811.

News of June 2017

26. Jun. 2017

EULAR contributes 70 years to the field of RMDs

EULAR has released a press release to international media circles in celebration of its 70th anniversary.

Read the text and comments from EULAR President Prof. Gerd Burmester and President-elect Prof. Johannes Bijlsma.

22. Jun. 2017

EULAR Campaign: Don't Delay, Connect Today

The EULAR Campaign, Don't Delay, Connect Today, encompasses the three pillars of the association, scientific, health professionals and patient organisations. It was launched in Madrid, Spain, in mid-June.

Find information toolkits on the dedicated webpage, watch the video and get involved!

14. Jun. 2017

POSTMENOPAUSAL WOMEN AT RISK OF FRACTURES COULD BE IDENTIFIED THROUGH GENETIC PROFILING

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference showed for the first time that genetic markers, identified in previous research as being linked to the development of osteoporosis, are also associated with the risk of fragility fractures in postmenopausal women.

14. Jun. 2017

NEW STUDY SHOWS FOR FIRST TIME LINK BETWEEN PASSIVE SMOKING IN CHILDHOOD AND RHEUMATOID ARTHRITIS

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference confirmed the link between active smoking and the risk of developing rheumatoid arthritis (RA). However, interestingly, it also suggested for the first time that in smokers, exposure to tobacco early in life through passive smoking in childhood significantly increased this risk.

14. Jun. 2017

NEW RELAPSE PREDICTION TOOL REDUCES COST OF RHEUMATOID ARTHRITIS TREATMENT

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 have shown that the combined use of two measurements to accurately predict the risk of relapse in patients with rheumatoid arthritis (RA) allows successful dose reduction (tapering) of their disease modifying anti-rheumatic drugs (DMARDs). This in turn increases the cost-effectiveness of each DMARD treatment.

14. Jun. 2017

NEW EFFECTIVE TREATMENTS FOR PSORIATIC ARTHRITIS PATIENTS

The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference revealed promising data supporting two new drug classes for the treatment of psoriatic arthritis (PsA).

14. Jun. 2017

GENES EXPLAIN HIGHER PREVALENCE OF CARDIOVASCULAR DISEASE IN CHRONIC IMMUNE MEDIATED INFLAMMATORY DISEASE PATIENTS

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 represent an important step towards characterising the genetic basis of cardiovascular disease (CVD) risk in chronic immune-mediated inflammatory diseases (IMID).

14. Jun. 2017

EXCESS RISK OF CARDIOVASCULAR EVENTS IN RHEUMATOID ARTHRITIS PATIENTS DECREASED SINCE START OF 21ST CENTURY

The results of a meta-analysis presented for the first time today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference showed that the excess risk of cardiovascular events in rheumatoid arthritis (RA) patients relative to the general population has significantly decreased since the year 2000.

14. Jun. 2017

EDUCATION FOR PEOPLE WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES AND EMPLOYERS CAN IMPROVE ABILITY TO WORK

The results of an educational programme implemented by the Galician Rheumatology League (LRG), presented today at the Annual European Congress of Rheumatology (EULAR) 2017, showed that providing education and advice to people with rheumatic and musculoskeletal disease (RMD) and their employers can make a significant difference to the ability to work.

14. Jun. 2017

BIOSIMILAR CONCERNS OF RHEUMATOLOGY PATIENTS BEING ADDRESSED BY NATIONAL PROGRAMME

To address the fear and insecurity expressed by rheumatology patients on being switched from a biologic to a biosimilar treatment for their arthritis, the Danish Rheumatism Association has participated in a national programme designed to ensure patients received independent information about biosimilars, along with closer monitoring of prescriptions to provide reassurance about their safety. The results of this initiative were presented today at the Annual European Congress of Rheumatology (EULAR) 2017.

14. Jun. 2017

PERSISTENT PAIN SHOWS UP INEFFICIENCY OF CURRENT PSORIATIC ARTHRITIS (PsA) TREATMENT

The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference have highlighted limitations in the current treatment of patients with Psoriatic Arthritis (PsA).

14. Jun. 2017

NURSES CRUCIAL IN IMPROVING UPTAKE OF POTENTIALLY LIFE-SAVING VACCINE IN VULNERABLE RHEUMATIC PATIENTS

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference showed that implementing a vaccination programme run by nursing staff dramatically improves pneumococcal vaccination coverage among vulnerable patients with chronic inflammatory rheumatic diseases.

14. Jun. 2017

NEW BLOOD TEST DETECTS STROKE AND HEART ATTACK RISK IN LUPUS PATIENTS WITH NO CARDIOVASCULAR SYMPTOMS

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference have shown that a specific biomarker detected in the blood of lupus patients with no symptoms of cardiovascular disease (CVD), thought to be at low risk of CVD based on traditional risk factors, is associated with the presence of atherosclerosis.

14. Jun. 2017

LOW-DOSE CT SCANNING IMPROVES ASSESSMENT OF ANKYLOSING SPONDYLITIS PATIENTS

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 showed that low dose computed tomography (LD-CT) is more sensitive than conventional radiographs (X-rays) in the monitoring of disease progression in patients with Ankylosing Spondylitis (AS).

14. Jun. 2017

COGNITIVE BEHAVIOUR THERAPY (CBT) SIGNIFICANTLY REDUCED DEPRESSION AND ANXIETY IN CHRONIC PAIN PATIENTS

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 has shown that Acceptance and Commitment Therapy, a form of cognitive behavioural therapy (CBT) that focuses on psychological flexibility and behaviour change, provided a significant reduction in self-reported depression and anxiety among patients participating in a pain rehabilitation programme.

14. Jun. 2017

BIOLOGICAL DMARD GUIDELINES ASSOCIATED WITH A REDUCED NEED FOR KNEE AND HIP REPLACEMENTS IN RA PATIENTS

The results of a Danish study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference showed that the incidence of total knee replacements (TKR) carried out on patients with rheumatoid arthritis (RA) started to decrease after the introduction of biological Disease-Modifying Anti-Rheumatic Drugs (bDMARDs) to national treatment guidelines.

14. Jun. 2017

PREVIOUS BACTERIAL INFECTION INCREASES RISK OF NEWLY-DIAGNOSED SJÖGREN’S SYNDROME

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 have shown a link between newly-diagnosed Sjögren’s syndrome (SjS) and previous infection with nontuberculous mycobacteria (NTM).

14. Jun. 2017

NEW TOOLS HELP EARLY DIAGNOSIS OF SYSTEMIC SCLEROSIS

The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference highlight the use of two new tools, which can potentially play a pivotal role in the early diagnosis of Systemic Sclerosis (SSc).

14. Jun. 2017

NEW IMAGING TECHNIQUE MAY HELP IDENTIFY JOINT INFLAMMATION IN CHILDREN EARLIER AND WITH GREATER CONFIDENCE

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 have confirmed that Fluorescence Optical Imaging (FOI), a technique used to visualise inflammation in arthritic joints, is as effective as ultrasound with Power Doppler (US / PD) at monitoring response to treatment in juvenile idiopathic arthritis (JIA). FOI was also found to be more effective than US / PD at detecting inflammation in the absence of symptoms and signs.

14. Jun. 2017

NEW DATA SUGGEST NO INCREASED CANCER RISK FOR RA PATIENTS PRESCRIBED BIOLOGICAL DMARDS

The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference should reassure rheumatologists regarding the risk of cancer from the use of biological disease modifying anti-rheumatic drugs (bDMARDs), including anti-TNF treatment, in patients with rheumatoid arthritis (RA).

14. Jun. 2017

NEW CLASS OF DRUG SIGNIFICANTLY REDUCES SPINE FRACTURE RISK IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference showed that, in postmenopausal women with osteoporosis, 12 months treatment with romosozumab was associated with rapid and large reductions in their risk of a vertebral fracture compared to placebo.

14. Jun. 2017

EARLY THERAPEUTIC INTERVENTION FOR PRE-RHEUMATOID ARTHRITIS (PRE-RA) PATIENTS SIGNIFICANTLY REDUCES RISK OF RA

The results of a meta-analysis presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference has demonstrated that early therapeutic intervention in patients with so-called “pre-rheumatoid arthritis” (pre-RA) significantly reduces the risk of the occurrence of rheumatoid arthritis (RA) in these patients at 52 weeks or more.

14. Jun. 2017

CONTINUING ANTI-TNF TREATMENT WITH CZP FOR RA DURING PREGNANCY: NO OR NEGLIGIBLE PLACENTAL TRANSFER

The results of a pharmacokinetic study presented at the Annual European Congress of Rheumatology (EULAR) 2017 showed no or negligible placental transfer of the anti-TNF drug certolizumab pegol (CZP) from mothers to infants during pregnancy.

14. Jun. 2017

BODY FAT AND WAIST SIZE LINKED TO INCREASED RISK OF DEVELOPING RHEUMATOID ARTHRITIS IN WOMEN

The results of a population study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 showed that, in women, being overweight or obese, as defined by body mass index (BMI*), abdominal obesity and a higher body fat percentage was associated with a higher risk of developing rheumatoid arthritis (RA).

1. Jun. 2017

EULAR launches 'RheumaMap’ in EU Parliament in Brussels

In a meeting of the Interest Group on Rheumatic and Musculoskeletal Diseases (RMDs), the “Research Roadmap to transform the lives of people with Rheumatic and Musculoskeletal Diseases” was launched in the European Parliament.